Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant

Holmgren, J ; Bourgeois, L ; Carlin, N ; Clements, J ; Gustafsson, B ; Lundgren, A ; Nygren, E ; Tobias, J ; Walker, R ; Svennerholm, A.-M

Vaccine, 2013-05, Vol.31 (20), p.2457-2464 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível